Many available sources of light therapy will deter the degeneration of Alzheimer’s and TBI, non-invasively. However, until someone large enough to afford FDA approval undertakes the initiative, the tragic onslaught of dementia will continue.

This video provides definitive evidence that it works for Alzheimer’s and TBI: https://youtu.be/46oBjzW5OJM

Adding neurofeedback will rapidly help improve some degree of cognition from the Alzheimer’s patient, but on its own will not stop degeneration.

The combination is the optimal therapy, a company called Lumineu (www.lumineu.com) has a home or in-clinic combination device and has acquired pending patents that cover these combinations. They are seeking investors.

I am a co-inventor of the patents they acquired, which we had help from the former Chief Patent Counsel of Medtronic, and the former patent attorney for J&J medical devices, helping us prosecute. I am helping Lumineu get the word out and generate funding.

The former head of neuroscience for DOD, who led over $800 million in R&D into traumatic brain injury (TBI), which studies show benefits from the identical therapy, is Lumineu’s CEO.

The company is seeking impact investors who wish to disrupt the industry with a new paradigm that can be minimally invasive, or non-invasive. Non-invasive is dramatically less expensive to get through FDA approvals, and with the new PET Scan markers for early Alzheimer’s detection, have a huge market potential.

Infrared penetrates transcranially, and effectively, in spite of folklore to the contrary. See the video evidence and the published literature.

Evidence in clinical trials shows that mesenchymal stem cells can be generated with light therapy and are regrowing cardiac tissue, in situ, in human clinical trials. We are collaborating with the core patent holders, to bring a new paradigm to the clinic, better than the biggest companies in outcomes and without morbidity, if done non-invasively.

This has the potential to be the next revolution in medicine.

As an example, just over 1 million pacemakers are implanted annually, generating well over $10 billion in high margin sales, and over a $100 billion market cap.

40 million patients have Alzheimer’s, and 20 million more TBI and other forms of dementia. Our automated home therapy device can drop the cost of treatment for 1 million patients from $50 billion to $10 billion, per year.

But, like hand washing after the discovery of the germ, it may take a long time to adaptation and use. The money is in minimally invasive, and we have that, as well.

The purpose of this post is to get the word out on one of the most tragic failures of the healthcare system to care about patient health.

Revenue and profits should have some semblance to effectiveness and quality, including patient health and lifestyle. Until they do, the industry will not live up to its potential, and millions will continue to die, needlessly.

This footnote is not appreciated or spoken in the device, community.

It should be a topic of discussion. Backing Lumineu and others like it, including Vielight, Thor Laser, Lite-Cure, and others who sell the devices (in the 800 to 830 nanometer range), but cannot claim their utility, because they cannot raise the cash to pursue the Alzheimer’s proven solution, are a sign of what is wrong with the healthcare system.

I post this so those with a concern for the devastation of Alzheimer’s can help us get the evidence needed to get FDA approval and make the solution available. All that is needed is capital to run the trials.

Mike Weiner – 239-603-6446 – phasemike@gmail.com
https://app.box.com/s/77bszm2x57zm1ukwsdjitygcqnxxuti5
my bio: www.lifeboat.com/ex/bios.michael.l.weiner

SCIENTISTS SHOW A WORKING SOLUTION FOR ALZHEIMER’S AND TBI IN VIDEO

This video provides definitive evidence that it works. https://youtu.be/46oBjzW5OJM This video link above, by Lew Lim, Ph.D., working with the leading

source: https://www.linkedin.com/groups/78665/78665-6163130129406062592